Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Coronary Circulation

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Integrating physical fitness and psychology: an in-depth discussion of exercise interventions for weight reduction among university students.

Frontiers in psychology·2026

Same author

Process-dependent niches of rpf-harboring microorganisms regulate nitrogen and carbon functional networks in full-scale activated sludge.

Environmental research·2026

Same author

Debt as a blessing: A capital screening mechanism.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Bifunctional Photochemical Performance Based on Pt-TiO<sub>2</sub> Hollow Sphere Schottky Junction: From Photocatalytic Hydrogen Production to Highly Sensitive Glucose Sensing.

Inorganic chemistry·2026

Same author

Amphiphilic Bonding Intercalation Reshapes Active Sites and Interlayer Microenvironment for Selective and Stable Seawater Oxidation.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

Exploring the use of AI-generated counterfactual chest X-rays to enhance diagnostic learning in medical education.

BMC medical education·2026

Search research articles

Related Experiment Video

Updated: May 26, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Coronary collateral growth--back to the future.

William M Chilian¹, Marc S Penn, Yuh Fen Pung

¹Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio 44272, USA. wchilian@neomed.edu

Journal of Molecular and Cellular Cardiology

|January 3, 2012

Summary

Coronary collateral circulation adapts to ischemia by vessel growth, but knowledge gaps hinder therapeutic potential. Understanding growth factors, genetics, and stem cells is crucial for patient treatment.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Experiment Videos

Last Updated: May 26, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Area of Science:

Cardiovascular Science
Physiology
Regenerative Medicine

Background:

Coronary collateral circulation is vital for heart adaptation to ischemia.
Native collaterals are microcirculation vessels (30-100 µM) that can remodel to macrocirculation size (>1000 µM).
Vessel expansion dramatically reduces blood flow resistance, protecting ischemic regions.

Purpose of the Study:

To review current understanding of coronary collateral growth in response to ischemia.
To identify knowledge gaps and controversies regarding factors stimulating collateralization.
To explore the roles of genetics and stem cells in collateral development.

Main Methods:

Literature review focusing on coronary collateral circulation adaptation.
Discussion of physiological and pathological conditions influencing collateral growth.
Analysis of causal factors, genetics, and stem/progenitor cell involvement.

Main Results:

Significant gaps exist in understanding the mechanisms of coronary collateral growth.
Controversies surround the precise stimuli for collateral expansion.
The roles of genetics and endogenous stem cells require further elucidation.

Conclusions:

Current knowledge of coronary collateral growth is insufficient for clinical application.
Further research is critical to unlock the potential of stimulating collateralization in patients.
Addressing these knowledge gaps is essential for developing new ischemic heart disease therapies.